Researchers from Queen Mary University of London have found that the next-generation target of rapamycin (TOR) pathway ...
Researchers from Queen Mary University of London's School of Biological and Behavioral Sciences, using the simple fission ...
News-Medical.Net on MSN
New TOR inhibitor rapalink-1 prolongs chronological lifespan in fission yeast
Researchers from Queen Mary University of London's School of Biological and Behavioural Sciences, using the simple fission yeast as a model, have shown that new TOR inhibitor rapalink-1 prolongs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback